Shields Health Solutions Partners With Baptist Health on Specialty Pharmacy

Why It Matters

The collaboration demonstrates how health‑system‑embedded specialty pharmacies can improve medication access, lower patient costs, and enhance clinical outcomes, a critical advantage as specialty drug spending accelerates.

Key Takeaways

• Shields launches on‑site specialty pharmacy at Baptist MD Anderson
• Initial focus on rheumatology, oncology to follow
• In‑house insurance navigation cuts patient out‑of‑pocket costs
• Integrated model boosts adherence, 92% activity continuity

Pulse Analysis

Integrated specialty pharmacies are emerging as a strategic response to soaring specialty drug expenditures, which are projected to exceed $600 billion in the United States by 2028. Health systems that embed pharmacy services within their clinical workflow can leverage electronic health records, reduce administrative friction, and provide real‑time support for high‑cost therapies. This model not only improves patient experience but also aligns with payer initiatives aimed at cost containment and value‑based care.

The Shields Health Solutions‑Baptist Health partnership brings that model to Jacksonville’s Baptist MD Anderson Cancer Center, targeting rheumatology patients first and adding oncology shortly thereafter. By situating the pharmacy on‑site and offering a direct‑to‑patient delivery option, the program eliminates common bottlenecks such as delayed prior authorizations and fragmented medication logistics. Comprehensive support services—including insurance navigation, financial assistance, and co‑pay management—are handled by pharmacists embedded in the care team, freeing clinicians to concentrate on treatment decisions rather than paperwork.

Evidence underscores the efficacy of this approach. A Vanderbilt University study highlighted improvements in medication adherence, faster treatment initiation, and higher patient satisfaction when specialty pharmacies are integrated into health‑system teams. Shields’ own 2025 outcomes report cites a 92% rate of uninterrupted daily activities among rheumatology patients, dwarfing the 50% industry benchmark. As more systems seek to replicate these results, integrated specialty pharmacies are poised to become a cornerstone of modern, patient‑centric care delivery.